HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyoshi Mori Selected Research

Diarrhea

1/2021[A case of severe colitis induced by the administration of pembrolizumab for pulmonary adenocarcinoma in a patient with ulcerative colitis].
12/2009A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510.
5/2003Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer.
1/2002Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyoshi Mori Research Topics

Disease

22Neoplasms (Cancer)
03/2022 - 12/2004
18Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2020 - 02/2002
13Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 07/2002
11Proteinuria
02/2022 - 07/2002
11Fibrosis (Cirrhosis)
01/2022 - 05/2002
10Acute Kidney Injury (Acute Renal Failure)
02/2019 - 12/2004
8Chronic Renal Insufficiency
04/2018 - 06/2008
7Infections
10/2022 - 07/2009
7Albuminuria
01/2018 - 10/2006
6Breast Neoplasms (Breast Cancer)
01/2021 - 12/2004
6Neutropenia
08/2016 - 03/2002
5Heart Failure
10/2022 - 01/2018
5Hypertrophy
06/2022 - 07/2002
5Chronic Kidney Failure (Chronic Renal Failure)
02/2022 - 11/2002
5Kidney Diseases (Kidney Disease)
11/2020 - 07/2006
5Neoplasm Metastasis (Metastasis)
01/2018 - 04/2005
5Lung Neoplasms (Lung Cancer)
01/2017 - 12/2004
4Carcinogenesis
01/2022 - 07/2009
4Glomerulonephritis
10/2021 - 05/2003
4Diarrhea
01/2021 - 01/2002
4Type 2 Diabetes Mellitus (MODY)
04/2018 - 09/2006
4Inflammation (Inflammations)
01/2018 - 01/2012
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2016 - 01/2002
4Reperfusion Injury
12/2014 - 12/2004
3Ischemia
10/2022 - 12/2004
3Nephrotic Syndrome (Syndrome, Nephrotic)
02/2022 - 09/2005
3Carcinoma (Carcinomatosis)
10/2019 - 12/2004
3Peritoneal Fibrosis
01/2018 - 01/2012
3Obesity
11/2017 - 09/2002
3Pneumonia (Pneumonitis)
08/2016 - 10/2006
3Hypoxia (Hypoxemia)
01/2013 - 10/2006
2Pathologic Constriction (Stenosis)
10/2022 - 06/2021
2Rectal Neoplasms (Rectal Cancer)
05/2021 - 04/2020
2Adenocarcinoma
01/2021 - 09/2008
2Idiopathic Pulmonary Fibrosis
01/2021 - 06/2014
2Adenocarcinoma of Lung
01/2021 - 09/2008
2Colitis
01/2021 - 10/2016
2Thrombotic Microangiopathies
11/2019 - 10/2019
2Thrombocytopenia (Thrombopenia)
10/2019 - 08/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 01/2016
2Anemia
10/2019 - 10/2006
2Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 01/2013
2Bacterial Infections (Bacterial Infection)
11/2017 - 02/2015
2Sclerosis
01/2017 - 07/2012
2Hypertension (High Blood Pressure)
01/2017 - 07/2012
2Nephritis
01/2017 - 12/2001

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2008
16Cisplatin (Platino)FDA LinkGeneric
10/2019 - 01/2002
16Lipocalin-2IBA
11/2017 - 12/2004
9CreatinineIBA
02/2019 - 11/2002
8Biomarkers (Surrogate Marker)IBA
04/2018 - 04/2005
6IronIBA
01/2022 - 03/2005
6Carboplatin (JM8)FDA LinkGeneric
05/2020 - 07/2006
6GemcitabineFDA Link
10/2019 - 07/2007
5Connective Tissue Growth FactorIBA
01/2018 - 05/2002
5Irinotecan (Camptosar)FDA LinkGeneric
08/2016 - 01/2002
5Paclitaxel (Taxol)FDA LinkGeneric
06/2012 - 12/2004
5Transforming Growth Factor beta (TGF-beta)IBA
07/2009 - 12/2001
4Pharmaceutical PreparationsIBA
02/2022 - 01/2011
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 01/2007
4AlbuminsIBA
01/2017 - 12/2013
4Vinorelbine (Navelbine)FDA LinkGeneric
01/2013 - 03/2002
4Docetaxel (Taxotere)FDA Link
11/2009 - 11/2002
3Histones (Histone)IBA
01/2022 - 03/2011
3Toll-Like Receptor 4IBA
01/2020 - 01/2014
3Hormones (Hormone)IBA
10/2019 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 10/2006
3Etoposide (VP 16)FDA LinkGeneric
08/2016 - 01/2002
3PlatinumIBA
01/2011 - 10/2006
3Pemetrexed (MTA)FDA Link
11/2009 - 12/2004
3SiderophoresIBA
07/2009 - 03/2005
2LDL Lipoproteins (beta Lipoproteins)IBA
02/2022 - 04/2014
2AnthracyclinesIBA
01/2022 - 10/2006
2Atrial Natriuretic Factor (ANF)IBA
11/2021 - 02/2019
2Serum AlbuminIBA
10/2021 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
05/2021 - 02/2010
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2021
2pembrolizumabIBA
01/2021 - 01/2021
2LigandsIBA
01/2020 - 01/2014
2Bevacizumab (Avastin)FDA Link
11/2019 - 06/2012
2human ERBB2 proteinIBA
10/2019 - 01/2018
2Progesterone Receptors (Progesterone Receptor)IBA
10/2019 - 12/2015
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2019 - 03/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2018 - 01/2017
2chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
01/2018 - 01/2012
2SodiumIBA
01/2018 - 01/2011
2Carrier Proteins (Binding Protein)IBA
11/2017 - 07/2009
2Oxygen (Dioxygen)IBA
11/2017 - 01/2013
2SaltsIBA
01/2017 - 07/2012
2FR 167653IBA
01/2017 - 09/2005
2p38 Mitogen-Activated Protein KinasesIBA
01/2017 - 09/2005
2AldosteroneIBA
01/2017 - 07/2012

Therapy/Procedure

20Drug Therapy (Chemotherapy)
03/2022 - 02/2002
14Therapeutics
05/2021 - 03/2002
8Radiotherapy
03/2022 - 02/2002
5Chemoradiotherapy
11/2016 - 10/2006
3Renal Dialysis (Hemodialysis)
10/2022 - 01/2015
3Combination Drug Therapy (Combination Chemotherapy)
08/2016 - 02/2004
2Hepatectomy
02/2022 - 12/2016
2Injections
01/2022 - 09/2009